VIQUPRIN TABLET

Country: Malasía

Tungumál: enska

Heimild: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Virkt innihaldsefni:

Aspirin; Glycine

Fáanlegur frá:

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

INN (Alþjóðlegt nafn):

Aspirin; Glycine

Einingar í pakka:

3 X 10 Tablets

Framleitt af:

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Upplýsingar fylgiseðill

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
________________________________________________________________________________________________________
_________________________________________________________________________________________________________
1
WHAT IS IN THIS LEAFLET
1.
What Viquprin is used for
2.
How Viquprin works
3.
Before you use Viquprin
4.
How to use Viquprin
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of Viquprin
8.
Product description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
WHAT VIQUPRIN IS USED FOR
Viquprin
is
used
as
a
platelet
aggregation
inhibitor
in
patients
following aortocoronary by-pass surgery,
to prevent graft occlusion. Conditions
where modification of platelet behavior
is
considered
beneficial,
including
transient
ischaemic
attacks,
secondary
prevention of myocardial infarction and
for prophylaxis against stroke, vascular
occlusion and deep vein thrombosis.
HOW VIQUPRIN WORKS
Aspirin
reduces
the
stickiness
of
platelets, where formation of clot is less
likely
to
be
occurred
in
the
blood
vessels.
Glycine helps to reduce gastric irritation
caused by aspirin.
BEFORE YOU USE VIQUPRIN
_- When you must not to use it _
Do not use Viquprin if you are known
hypersensitivity to any ingredients in
this medicine.
_ _
_Pregnancy and lactation _
•
Do
not
take
Viquprin
if
you
are
pregnant,
trying
to
get
pregnant
or
think you may be pregnant.
•
Do not take Viquprin
_ _
if you are breast-
feeding.
Ask
your
doctor
or
pharmacist
for
advice
before
taking
any medicine.
_ _
_- Before you start to use it _
Tell your doctor or pharmacist if:
•
You
are
pregnant
or
plan
to
get
pregnant.
_ _
•
You are breast-feeding.
_ _
_ _
_- Taking other medicines _
Tell your doctor if you are taking any
other
medicines,
including
any
that
you buy without a prescription from a
pharmacy, supermarket or health food
shop.
HOW TO USE VIQUPRIN
_- How much to use_
For oral use only.
Gastric irritation may be reduced by
taking doses after food.
_Adults_
: Take on

Vara einkenni

Important Information. Please read carefully.
VIQUPRIN
TABLET
WHAT IS VIQUPRIN?
Description, Dosage form and Packaging
VIQUPRIN is a White to off-white, round, normal convex tablet, plain
on both sides.
Each tablet contains Aspirin 100mg and Glycine 45mg. Available in pack
size of 30 tablets per box (10 tablets per blister,
and 3 blisters in a box).
WHAT IS VIQUPRIN USED FOR?
VIQUPRIN is used as a platelet aggregation inhibitor in patients
following aortocoronary by-pass surgery, to prevent graft
occlusion. Conditions where modification of platelet behavior is
considered beneficial, including transient ischaemic attacks,
secondary prevention of myocardial infarction and for prophylaxis
against stroke, vascular occlusion and deep vein
thrombosis.
HOW VIQUPRIN WORKS?
VIQUPRIN contains aspirin and glycine.
Aspirin reduces the stickiness of platelets, where formation of clot
is less likely to be occurred in the blood vessels.
Glycine helps to reduce gastric irritation caused by aspirin.
Pharmacodynamics
Aspirin is a salicylate NSAID which inhibits platelet aggregation, in
addition to its analgesic, anti-inflammatory, and
antipyretic properties.
Glycine is a non-essential aliphatic amino acids. It is used in the
aspirin preparation as to reduce gastric irritation.
Pharmacokinetics
Aspirin is absorbed rapidly from the gastrointestinal tract when taken
orally. Once absorbed, aspirin is rapidly converted to
salicylate, but during the first 20 minutes after an oral dose aspirin
is the main form of the drug in the plasma. Aspirin is 80
to 90% bound to plasma proteins and is widely distributed; its volume
of distribution is reported to be 170 mL/kg in adults.
Both aspirin and salicylate have pharmacological activity although
only aspirin has an anti-platelet effect. Salicylate is
extensively bound to plasma proteins and is rapidly distributed to all
body parts. Salicylate is mainly eliminated by hepatic
metabolism; the metabolites include salicyluric acid, salicyl phenolic
glucuronide, salicylic acyl glucuronide, gentisic a